Skip to main content
Lupin Ltd logo

Lupin Ltd — Investor Relations & Filings

Ticker · LUPIN ISIN · INE326A01037 LEI · 335800HHXTESDEE2FC65 BSE.NS Manufacturing
Open in API
Filings indexed 3,180 across all filing types
Latest filing 2022-08-09 Call Transcript
Country IN India
Listing BSE.NS LUPIN

About Lupin Ltd

https://www.lupin.com/

Lupin Ltd is a global pharmaceutical organization specializing in the development, manufacturing, and marketing of a comprehensive range of generic and branded formulations, biotechnology products, and active pharmaceutical ingredients. The company holds a significant market position in therapeutic segments such as cardiovascular, diabetology, asthma, pediatrics, gastrointestinal, anti-infectives, and non-steroidal anti-inflammatory drugs. It is notably recognized for its leadership in the anti-tuberculosis medication sector. With a strong emphasis on research and development, Lupin focuses on complex generics, specialty medicines, and biosimilars. The company operates advanced manufacturing facilities and maintains a substantial commercial presence across major global markets, including North America, Europe, and the Asia-Pacific region, delivering affordable and high-quality healthcare solutions.

Recent filings

Filing Released Lang Actions
Transcript of the Q1 FY2023 Earnings Conference Call held on Thursday, August 4, 2022.
Call Transcript Classification · 100% confidence The document is a transcript of the Q1 FY2023 earnings conference call for Lupin Limited, dated August 4, 2022. It includes detailed management commentary on financial results, business performance, sales figures, margins, and Q&A with analysts. The presence of a full transcript of the earnings call, including management remarks and Q&A, clearly identifies this as a Call Transcript (CT). The document is lengthy (15,000 characters) and contains substantive discussion of quarterly financial results, consistent with an earnings call transcript rather than a brief earnings release or other report type.
2022-08-09 English
Recording of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings Classification · 95% confidence The document is a short notice informing about the availability of the audio/video recording of the Earnings Call for Q1 FY 2023 on the company's website. It references the earnings call but does not contain the transcript or financial data itself. The document is only 1501 characters long and serves as an announcement for dissemination. According to the rules, such a document is classified as a Regulatory Filing (RNS) because it is an announcement of the earnings call recording, not the transcript or the earnings release itself.
2022-08-04 English
Audio/Video recording of the Earnings Call - Q1 FY 2023.
Regulatory Filings Classification · 95% confidence The document is a short communication dated August 4, 2022, addressed to stock exchanges, informing about the availability of the audio/video recording of the Earnings Call for Q1 FY 2023 on the company's website. It references the SEBI Listing Obligations and Disclosure Requirements Regulations, indicating a regulatory compliance announcement. The document does not contain the transcript or financial data itself, only a notice that the recording is hosted online. The length is only 1503 characters, which is very short and consistent with an announcement rather than a full report or transcript. Therefore, this is not the Earnings Release (ER) or Call Transcript (CT) itself, but an announcement about the availability of the call recording. According to the rules, such announcements are best classified as Regulatory Filings (RNS) since it is a regulatory disclosure that does not fit other categories and is not the report itself.
2022-08-04 English
Annual General Meeting
Regulatory Filings Classification · 90% confidence The document text is extremely short (563 characters) and contains only references to omitted pictures with no substantive text content or financial data. There is no indication of any report content, financial statements, or regulatory information. Given the lack of any detailed information and the presence of only images, this document does not fit into any specific report category. It is best classified as a Regulatory Filing (RNS), which serves as a fallback category for miscellaneous filings that do not fit other categories.
2022-08-04 English
Scrutinizer''s Report for declaration of voting results at the Fortieth Annual General Meeting of the Company, held on Wednesday, August 3, 2022, at 4.00 p.m. (IST) through Video Conferencing/Other .
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled 'Scrutinizer's Report' and is addressed to stock exchanges and the Department of Corporate Services, indicating it is an official filing related to a company's Annual General Meeting (AGM). It references the Companies Act, 2013 and related rules, and details the voting process and results for resolutions passed at the Fortieth AGM held on August 3, 2022. The content includes consolidated voting results for various ordinary resolutions such as adoption of financial statements, dividend declaration, director re-appointment, and auditor remuneration ratification. The document is a detailed report on the voting outcome rather than the AGM presentation materials or the Annual Report itself. It is not a simple announcement or notice but a formal report on voting results. This matches the definition of 'Declaration of Voting Results & Voting Rights Announcements (DVA)'. The document length (over 13,000 characters) and detailed voting data confirm it is not a brief announcement or a regulatory filing. Therefore, the correct classification is DVA with high confidence.
2022-08-04 English
Disclosure pursuant to Loss of Share Certificate by Shareholders.
Regulatory Filings Classification · 95% confidence The document is an intimation under Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) 2015, concerning details of loss of share certificates and stop transfer requests. It is addressed to the stock exchange and contains details of the shareholder and share certificates. This type of document is a regulatory announcement related to share certificate status and does not contain financial data, management changes, or voting results. It fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2022-08-04 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.